WO2005063227A1 - Process for producing triterpene composition - Google Patents

Process for producing triterpene composition Download PDF

Info

Publication number
WO2005063227A1
WO2005063227A1 PCT/JP2004/019428 JP2004019428W WO2005063227A1 WO 2005063227 A1 WO2005063227 A1 WO 2005063227A1 JP 2004019428 W JP2004019428 W JP 2004019428W WO 2005063227 A1 WO2005063227 A1 WO 2005063227A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
callus
producing
triterpene composition
perilla
Prior art date
Application number
PCT/JP2004/019428
Other languages
French (fr)
Japanese (ja)
Inventor
Futoshi Matsuyama
Takashi Yoshida
Tsutomu Hatano
Shoko Taniguchi
Original Assignee
Use-Techno Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Use-Techno Corporation filed Critical Use-Techno Corporation
Priority to JP2005516669A priority Critical patent/JPWO2005063227A1/en
Publication of WO2005063227A1 publication Critical patent/WO2005063227A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Definitions

  • the present invention relates to a method for producing a triterpene composition, a triterpene composition, and a callus for use in producing a triterpene composition.
  • Triterpenes such as corosolic acid, tolmentic acid, and maslinic acid are known to be useful substances that exhibit pharmacological activities such as blood sugar lowering action, and are extracted as components from natural plants. Examples of obtaining these triterpenes have been reported so far.
  • Non-Patent Document 1 As a plant containing corosolic acid, for example, banaba (Lagerstroemia speciosa) is known (for example, Non-Patent Document 1), and as a plant containing tormentetic acid, for example, Tigerella polyphyla (Tiarella polyphyla) ) Is known (for example, Non-Patent Document 2), and as a plant containing maslinic acid, for example, Olive (Olea europasea) is known (for example, Patent Document 1).
  • banaba Laagerstroemia speciosa
  • tormentetic acid for example, Tigerella polyphyla (Tiarella polyphyla)
  • maslinic acid for example, Olive (Olea europasea) is known (for example, Patent Document 1).
  • Patent document 1 International publication 03Z057224 pamphlet
  • Non-Patent Document 1 "Pharmacology and Therapy", 1999, Vol. 27, No. 6, p. 1075— p. 1077
  • Non-Patent Document 2 Archives of Pharmacal Research, Korea, 2002 , 25 volumes, No. 1, p. 57— p. 60
  • triterpenes such as corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3-oxo-l-ul-12-en-28-oic acid and maslinic acid can be chemically synthesized at low cost. There is no known method.
  • an object of the present invention is to provide at least one triterpene selected from the group consisting of corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3oxo-urose-12ene-28 euic acid and maslinic acid.
  • Another object of the present invention is to provide a means for stably and efficiently supplying a triterpene composition containing the same.
  • Callus culture is a technique for culturing calli induced by culturing parts of leaves, stems, roots, and the like cut out of a plant on a medium, and is used for basic research on biosynthesis of metabolites. May be
  • the present inventors used banapa, vegetation, perilla, or guava as an original plant for inducing callus, and cultured the induced callus together with a specific plant hormone.
  • the present inventors have found that specific triterpenes are produced with high efficiency in calli, and have completed the present invention.
  • the method for producing a triterpene composition of the present invention is characterized in that a callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones,
  • This is a method for producing a triterpene composition containing at least one triterpene selected from the group consisting of corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3oxourose-12-en-28 euic acid and maslinic acid. .
  • a triterpene composition of the present invention it is preferable to subculture callus.
  • a triterpene composition can be continuously obtained from the callus induced by Capana, such as banaba, without inducing another new virus.
  • Calli can also induce leaf, seed, stem, shoot apex, root or germ cell forces. By inducing such calligraphy, it becomes possible to obtain a triterpene composition efficiently in a shorter period of time.
  • the cultured callus contains maslinic acid, corosolic acid in an amount of 4 to 10 times the weight of maslinic acid, and tormentetic acid in an amount of 2 to 8 times the weight of maslinic acid. It is preferable to contain 1.5 to 4 times the amount of 2 ⁇ , 19 ⁇ -dihydroxy-3-oxo-1-urethane-12-28-ic acid!
  • corosolic acid which is highly useful in terms of blood sugar lowering action, is highly purified. It is important that the ratio of corosolic acid to maslinic acid is high, to make it easier to obtain at a high degree.
  • the present invention also provides a callus derived from banapa, vegetation, perilla, or guano and used for the above production method.
  • the power of the present invention derived from vanapa, vegetation, perilla or guava is corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-13-oxo-lour —12-en-28-oic acid And a large amount of triterpenes such as maslinic acid.
  • a triterpene composition comprising at least one can be provided. This triterpen composition can be used as a raw material for health foods, medicines, cosmetics and the like.
  • the present invention further provides a triterpene of corosolic acid, tolmentic acid, 2a, 19 ⁇ -dihydroxy-3-oxo-urus-12-en-28-oic acid or maslinic acid from this triterpene composition. Is provided by isolating and purifying the compound. By applying this production method, a high-purity triterpene that can be used for pharmaceuticals and the like can be obtained with high efficiency.
  • a triterpene composition containing at least one selected from the group consisting of carp can be stably supplied at a high efficiency.
  • callus (undifferentiated cell mass derived from a plant cell) is induced from banapa, vegetation, perilla or guava.
  • Banaba scientific name: Lager stroemia speciosa, Linn. Or Pers. Is a plant belonging to the family Araceae, and is used as a street ⁇ and its leaves are used as a traditional herbal medicine in the Philippines.
  • Callus is induced by naturally growing power or artificially cultivated banana or vegetation. , Perilla or guava can be used. In order to efficiently obtain a triterpene composition in a short-term culture, it is more preferable to induce leaf, seed, stem, shoot apex, root or germ cell callus, and more preferably to induce leaf or seed force. In addition, calli may be induced from the prepared protoplasts with these site forces!
  • Callus induction is performed by, for example, sterilizing a site such as a leaf from which a force such as a banaba is cut out with sodium hypochlorite, cutting the portion to an appropriate size with a scalpel, and transplanting the force into a medium. Cultivation methods can be adopted.
  • the callus is preferably induced in a solid medium such as a Linsmeier-Skoog agar medium (hereinafter referred to as "LS agar medium”) which can be induced in a solid medium or a liquid medium.
  • LS agar medium Linsmeier-Skoog agar medium
  • plant hormones other than indoleacetic acid used in combination with indoleacetic acid include potato-inetin, 1-naphthaleneacetic acid, 6-benzylazidenine, and the like, and potato-inetin is particularly preferred.
  • the callus is preferably cultured in a solid medium such as LS agar medium under aseptic conditions at 20-30 ° C in a dark place.
  • Cultivated callus power [0026] Cultivated callus power [0026]
  • the triterpene composition can be obtained directly, or a part of the cultured callus is transplanted to another new solid medium or liquid medium and cultured again, that is, from the callus subjected to subculture. A triterpene composition can also be obtained. By repeating subculture, a triterpene composition can be stably obtained over a long period of time.
  • a part of the previously cultured callus may be used as it is, or a microplast may be prepared from a part of the cultured callus, and the microplast may be placed in a liquid medium. May be used for suspension culture.
  • the conditions for subculture are as follows: Preferably, the conditions are the same as those described above.
  • the culture period for one passage in the subculture is preferably 5 to 30 days. The subculture can be continued while renewing the generation as long as the production amount of the target triterpene in the callus is not significantly reduced.
  • corosolic acid and tormentetic acid have great utility in terms of pharmacological activity and the like. Is preferably large. Specifically, maslinic acid, corosolic acid in an amount of 4 to 10 times the weight of maslinic acid, 2 to 6 times the amount of tolmentic acid, 1.5 to 4 times the amount of 2 ⁇ , 19 ⁇ -dihydroxy-l-oxo-unoleth-l-l-en-28-oitic acid.
  • a method of quantifying the content of triterpene contained in the callus a method of analyzing components extracted from the cultured callus using methanol or the like by liquid chromatography and quantifying from the area of the obtained chromatogram is used. Can be suitably adopted.
  • the extract obtained by extracting the cultured callus by using a known method is obtained by using corosolic acid, tonomenthetic acid, 2,19-dihydroxy-13-year-old quinone-unoleth-12-e.
  • This is a triterpene composition containing a large amount of itic acid and maslinic acid.
  • the triterpene composition can be used as a raw material for health foods or the like, or may be further purified to remove unnecessary components.
  • Extraction from the cultured callus may be performed using raw callus after the culture, or may be performed using a callus that has been dried and crushed with force!
  • the extraction solvent it is preferable to use a hydrophilic solvent such as water or an alcohol such as methanol or ethanol, and it is more preferable to use a heated water-alcohol mixed solvent.
  • a dry callus crushed material (raw material) is mixed with ethanol or an aqueous ethanol solution (ethanol content of 50 to 80% by weight) 5 to 20 times, preferably 8 to 10 times the weight of the raw material.
  • ethanol or an aqueous ethanol solution ethanol content of 50 to 80% by weight
  • a method of refluxing and repeating this extraction 2-3 times can be suitably used.
  • the triterpene composition When the amount of the triterpene composition is large, the triterpene composition is suspended in water and distributed to ether or hexane to remove low-polar components, and then the aqueous layer is treated with diaion -20. It is preferable to sequentially elute with water, methanol and acetone using column chromatography or the like, and to separate and purify the methanol-eluted fraction by silica gel column chromatography or the like.
  • Corosolic acid, tolmentic acid, 2 ⁇ , 19 ⁇ -dihydroxy-3-oxourus-12-en-28 euic acid or maslinic acid obtained by isolation and purification as described above are At least 90.0% by weight or more,
  • it contains 98.0% by weight or more, even more preferably 99.9% by weight or more.
  • the triterpene composition of the present invention is obtained by the above-described method, and is represented by corosolic acid represented by the following chemical formula (1), tolmentic acid represented by the following chemical formula (2), and represented by the following chemical formula (3) 2 OL, 19
  • Triterpene compositions containing these triterpenes are known to have pharmacological activities such as blood glucose level lowering activity and antitumor activity, respectively, and can be used as raw materials for health foods and medicines.
  • the highly pharmacologically active corosori Triterpene compositions containing carboxylic acid and tolmentic acid are particularly useful.
  • LS agar medium with ⁇ ⁇ ⁇ of 5.8 was prepared in an Erlenmeyer flask by adding 10 ⁇ of indoleacetic acid and 10 ⁇ of force inetine as plant hormones, and sterilized banana leaves were placed on the LS agar. The callus was induced by culturing in a dark place at ° C.
  • the induced calli were cultured and grown on an LS agar medium supplemented with 10 M of indole acetic acid and 10 M of force inetine for 3 weeks, and the grown calli were extracted by cold immersion in methanol.
  • the triterpene content of the cultured calli was determined from the area of the peak corresponding to each triterpene in the chromatogram (ultraviolet absorptiometer, detection wavelength: 220 nm) obtained by performing chromatographic analysis.
  • the content of triterpene in the original plant (banapa leaf) before callus induction was determined by the same method. The results are shown in Table 1.
  • Ursolic acid 0.5 0.8 0.2 I .Q Oleanolic acid 0.4 0.3 0.1 0.5 Maslinic acid 1.6 1.0 0.2 1.0

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A process for producing a triterpene composition which comprises culturing a callus induced from banaba, loquat, perilla, or guava together with indoleacetic acid and a vegetable hormone other than the acid and obtaining from the cultured callus a triterpene composition which contains at least one member selected from the group consisting of corosolic acid, tormentic acid, 2α,19α-dihydroxy-3-oxours-12-en-28-oic acid, and maslinic acid.

Description

明 細 書  Specification
トリテルペン組成物の製造方法  Method for producing triterpene composition
技術分野  Technical field
[0001] 本発明は、トリテルペン組成物の製造方法、トリテルペン組成物及びトリテルペン組 成物の生産に用いるためのカルスに関する。  The present invention relates to a method for producing a triterpene composition, a triterpene composition, and a callus for use in producing a triterpene composition.
背景技術  Background art
[0002] コロソリン酸、トルメンテイツク酸及びマスリン酸といったトリテルペンは、それぞれ血 糖値低下作用などの薬理活性を示す有用な物質であることが知られており、天然の 植物から抽出される成分として、これらトリテルペンが得られた例がこれまでにも報告 されている。  [0002] Triterpenes such as corosolic acid, tolmentic acid, and maslinic acid are known to be useful substances that exhibit pharmacological activities such as blood sugar lowering action, and are extracted as components from natural plants. Examples of obtaining these triterpenes have been reported so far.
[0003] コロソリン酸を含有する植物としては、例えば、バナバ(Lagerstroemia speciosa )が知られており(例えば、非特許文献 1)、トルメンテイツク酸を含有する植物としては 、例えば、ズダャクシュ (Tiarella polyphyla)が知られており(例えば、非特許文献 2)、マスリン酸を含有する植物としては、例えば、ォリーブ(Olea europasea)が知 られて ヽる(例えば、特許文献 1)。  [0003] As a plant containing corosolic acid, for example, banaba (Lagerstroemia speciosa) is known (for example, Non-Patent Document 1), and as a plant containing tormentetic acid, for example, Tigerella polyphyla (Tiarella polyphyla) ) Is known (for example, Non-Patent Document 2), and as a plant containing maslinic acid, for example, Olive (Olea europasea) is known (for example, Patent Document 1).
特許文献 1:国際公報 03Z057224号パンフレット  Patent document 1: International publication 03Z057224 pamphlet
非特許文献 1 :「薬理と治療」、 1999年、 27卷、 6号、 p. 1075— p. 1077 非特許文献 2 :アーカイブズ ォブ ファーマカル リサーチ(Archives of Pharma cal Reserch)、韓国、 2002年、 25卷、 1号、 p. 57— p. 60  Non-Patent Document 1: "Pharmacology and Therapy", 1999, Vol. 27, No. 6, p. 1075— p. 1077 Non-Patent Document 2: Archives of Pharmacal Research, Korea, 2002 , 25 volumes, No. 1, p. 57— p. 60
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] し力しながら、植物中のトリテルペンの含有量は必ずしも多いものではなぐトリテル ペンが効率的に得られるとはいえな力つた。さらに、人工的に栽培する場合にもその 生育には少なくとも数週間以上の期間を要し、トリテルペンの含有量は天候や栽培 地の土壌の影響を受けやすいため、供給の安定性の点でも問題があった。  [0004] However, the content of triterpenes in plants is not always high, but triterpenes are not always efficiently obtained. Furthermore, even when artificially cultivated, its growth requires at least several weeks or more, and the content of triterpene is easily affected by the weather and the soil of the cultivation area. was there.
[0005] また、コロソリン酸、トルメンテイツク酸、 2 α , 19 α—ジヒドロキシー 3—ォキソ一ウルス一 12—ェンー 28—オイック酸及びマスリン酸といったトリテルペンを安価に化学合成でき る手法も知られていない。 [0005] In addition, triterpenes such as corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3-oxo-l-ul-12-en-28-oic acid and maslinic acid can be chemically synthesized at low cost. There is no known method.
[0006] そこで本発明の目的は、コロソリン酸、トルメンテイツク酸、 2 α , 19 αージヒドロキシー 3 ォキソ—ウルス— 12 ェン— 28 オイック酸及びマスリン酸力もなる群より選ばれる 少なくとも一種のトリテルペンを含むトリテルペン組成物を、安定して高効率で供給で きる手段を提供することにある。  [0006] Therefore, an object of the present invention is to provide at least one triterpene selected from the group consisting of corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3oxo-urose-12ene-28 euic acid and maslinic acid. Another object of the present invention is to provide a means for stably and efficiently supplying a triterpene composition containing the same.
課題を解決するための手段  Means for solving the problem
[0007] カルス培養は、植物から切り出した葉、茎、根などの部位を培地上で培養すること によって誘導されるカルスを培養する技術であり、代謝産物の生合成の基礎研究な どに用いられることがある。 [0007] Callus culture is a technique for culturing calli induced by culturing parts of leaves, stems, roots, and the like cut out of a plant on a medium, and is used for basic research on biosynthesis of metabolites. May be
[0008] 本発明者らは、このカルス培養において、カルスを誘導する原植物としてバナパ、 ビヮ、シソ又はグアバを用い、誘導されたカルスを特定の植物ホルモンとともに培養 することにより、培養されたカルス中に特定のトリテルペンが高効率に産生されること を見出し、本発明を完成させるに至った。  [0008] In the callus culture, the present inventors used banapa, vegetation, perilla, or guava as an original plant for inducing callus, and cultured the induced callus together with a specific plant hormone. The present inventors have found that specific triterpenes are produced with high efficiency in calli, and have completed the present invention.
[0009] すなわち、本発明のトリテルペン組成物の製造方法は、バナパ、ビヮ、シソ又はグァ ノ から誘導されるカルスを、インドール酢酸及びこれ以外の植物ホルモンとともに培 養し、培養したカルスから、コロソリン酸、トルメンテイツク酸、 2 α , 19 α—ジヒドロキシ —3 ォキソ ウルス— 12—ェンー 28 オイック酸及びマスリン酸からなる群より選ばれる 少なくとも一種のトリテルペンを含むトリテルペン組成物を得る製造方法である。  [0009] That is, the method for producing a triterpene composition of the present invention is characterized in that a callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones, This is a method for producing a triterpene composition containing at least one triterpene selected from the group consisting of corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3oxourose-12-en-28 euic acid and maslinic acid. .
[0010] 本発明のトリテルペン組成物の製造方法では、カルスを継代培養することが好まし い。カルスを継代培養することで、バナバ等カゝら誘導したカルスから、新たに別の力 ルスを誘導することなく継続的にトリテルペン組成物を得ることができる。  [0010] In the method for producing a triterpene composition of the present invention, it is preferable to subculture callus. By subculturing the callus, a triterpene composition can be continuously obtained from the callus induced by Capana, such as banaba, without inducing another new virus.
[0011] カルスは、葉、種子、茎、茎頂、根又は胚細胞力も誘導することができる。これらの 部位カゝらカルスを誘導することで、より短期間で効率よくトリテルペン組成物を得ること が可能になる。  [0011] Calli can also induce leaf, seed, stem, shoot apex, root or germ cell forces. By inducing such calligraphy, it becomes possible to obtain a triterpene composition efficiently in a shorter period of time.
[0012] 培養したカルスには、マスリン酸と、マスリン酸の重量に対して 4一 10倍量のコロソリ ン酸と、マスリン酸の重量に対して 2— 8倍量のトルメンテイツク酸と、 1. 5— 4倍量の 2 α , 19 α—ジヒドロキシー 3 ォキソ一ウルス一 12 ェンー 28 オイック酸とを含んで!/、る ことが好ましい。特に、血糖値低下作用などの点で有用性の高いコロソリン酸を高純 度で得ることを容易にするため、マスリン酸に対するコロソリン酸の比率が高いことが 重要である。 [0012] The cultured callus contains maslinic acid, corosolic acid in an amount of 4 to 10 times the weight of maslinic acid, and tormentetic acid in an amount of 2 to 8 times the weight of maslinic acid. It is preferable to contain 1.5 to 4 times the amount of 2α, 19α-dihydroxy-3-oxo-1-urethane-12-28-ic acid! In particular, corosolic acid, which is highly useful in terms of blood sugar lowering action, is highly purified. It is important that the ratio of corosolic acid to maslinic acid is high, to make it easier to obtain at a high degree.
[0013] 本発明はまた、バナパ、ビヮ、シソ又はグアノ から誘導され、上記製造方法に用い るためのカルスを提供する。バナパ、ビヮ、シソ又はグアバから誘導される本発明の力 ルスは、コロソリン酸、トルメンテイツク酸、 2 α , 19 α—ジヒドロキシ一 3—ォキソ一ウルス —12-ェン— 28-オイック酸及びマスリン酸といったトリテルペンを多く含有する。  [0013] The present invention also provides a callus derived from banapa, vegetation, perilla, or guano and used for the above production method. The power of the present invention derived from vanapa, vegetation, perilla or guava is corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-13-oxo-lour —12-en-28-oic acid And a large amount of triterpenes such as maslinic acid.
[0014] 従って、上記製造方法によって得られ、コロソリン酸、トルメンテイツク酸、 2 α , 19 α —ジヒドロキシー 3—ォキソ—ウルス— 12—ェンー 28—オイック酸及びマスリン酸からなる 群より選ばれる少なくとも一種を含むトリテルペン組成物が提供可能となる。このトリテ ルペン組成物は健康食品、医薬、化粧品などの原料として用いることができる。  Therefore, it is obtained from the above production method and is selected from the group consisting of corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3-oxo-urose-12-en-28-oic acid and maslinic acid. A triterpene composition comprising at least one can be provided. This triterpen composition can be used as a raw material for health foods, medicines, cosmetics and the like.
[0015] 本発明はさらに、このトリテルペン組成物から、コロソリン酸、トルメンテイツク酸、 2 a , 19 αージヒドロキシー 3—ォキソ—ウルス— 12—ェンー 28—オイック酸又はマスリン酸そ れぞれのトリテルペンを単離、精製して得る製造方法を提供する。この製造方法を適 用することで、医薬品等に用いることの可能な高純度のトリテルペンを高効率で得る ことができる。  [0015] The present invention further provides a triterpene of corosolic acid, tolmentic acid, 2a, 19α-dihydroxy-3-oxo-urus-12-en-28-oic acid or maslinic acid from this triterpene composition. Is provided by isolating and purifying the compound. By applying this production method, a high-purity triterpene that can be used for pharmaceuticals and the like can be obtained with high efficiency.
発明の効果  The invention's effect
[0016] 本発明のトリテルペン組成物の製造方法によれば、コロソリン酸、トルメンテイツク酸 、 2 α , 19 α—ジヒドロキシー3—ォキソ—ウルス— 12—ェン—28—オイック酸及びマスリン 酸カゝらなる群より選ばれる少なくとも一種を含むトリテルペン組成物を、安定して高効 率で供給できる。  According to the method for producing a triterpene composition of the present invention, corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3-oxo-urus-12-en-28-oic acid, and maslinic acid A triterpene composition containing at least one selected from the group consisting of carp can be stably supplied at a high efficiency.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0017] 以下に、本発明を実施するための形態について、詳細に説明する。 Hereinafter, embodiments for carrying out the present invention will be described in detail.
[0018] 本発明のトリテルペン組成物の製造方法においては、バナパ、ビヮ、シソ又はグァ バからカルス (植物細胞から誘導された未分化の細胞塊)を誘導する。 In the method for producing a triterpene composition of the present invention, callus (undifferentiated cell mass derived from a plant cell) is induced from banapa, vegetation, perilla or guava.
[0019] これらの中でも、バナバ力 カルスを誘導することが好ましい。バナバ(学名: Lager stroemia speciosa、 Linn.又は Pers. )は、ミソハギ科に属する植物であり、街路 榭として用いられる他、その葉はフィリピンで伝承生薬として使用されている。 [0019] Among them, it is preferable to induce banaba calli. Banaba (scientific name: Lager stroemia speciosa, Linn. Or Pers.) Is a plant belonging to the family Araceae, and is used as a street 、 and its leaves are used as a traditional herbal medicine in the Philippines.
[0020] カルスの誘導には、天然に自生している力、或いは人工的に栽培したバナノ 、ビヮ 、シソ又はグアバを用いることができる。短期間の培養で効率よくトリテルペン組成物 を得るために、葉、種子、茎、茎頂、根又は胚細胞力 カルスを誘導することが好まし ぐ葉又は種子力も誘導することがより好ましい。また、これら部位力も調製したプロト プラストからカルスを誘導してもよ!/、。 [0020] Callus is induced by naturally growing power or artificially cultivated banana or vegetation. , Perilla or guava can be used. In order to efficiently obtain a triterpene composition in a short-term culture, it is more preferable to induce leaf, seed, stem, shoot apex, root or germ cell callus, and more preferably to induce leaf or seed force. In addition, calli may be induced from the prepared protoplasts with these site forces!
[0021] カルスの誘導は、例えば、バナバ等力も切り出した葉などの部位を、次亜塩素酸ナ トリウムなどで滅菌処理後、メスで適当な大きさに切るなどして力も培地に移植して培 養する方法を採用できる。  [0021] Callus induction is performed by, for example, sterilizing a site such as a leaf from which a force such as a banaba is cut out with sodium hypochlorite, cutting the portion to an appropriate size with a scalpel, and transplanting the force into a medium. Cultivation methods can be adopted.
[0022] カルスは固体培地又は液体培地中で誘導できる力 リンスマイァ一一スターグ (Lins maier~Skoog)寒天培地(以下、「LS寒天培地」という。)などの固体培地で誘導す ることが好ましい。 [0022] The callus is preferably induced in a solid medium such as a Linsmeier-Skoog agar medium (hereinafter referred to as "LS agar medium") which can be induced in a solid medium or a liquid medium.
[0023] 誘導されたカルスを、インドール酢酸及びこれ以外の植物ホルモンを添カ卩した培地 で培養して増殖させることで、カルス中にトリテルペンが多く産生される。バナパ、ビヮ 、シソ又はグアバから誘導されるカルスの培養においては、植物ホルモンとしてインド ール酢酸及びこれ以外の植物ホルモンを組み合わせて用いることが特に重要であり 、これら以外の植物ホルモンのみを用いた場合と比較して、カルス増殖及び該カルス 中でトリテルペン産生の効率が著しく向上する。  [0023] By culturing the induced callus in a medium supplemented with indoleacetic acid and other plant hormones and growing the same, a large amount of triterpene is produced in the callus. It is particularly important to use indoleacetic acid and other plant hormones in combination in cultivating calli derived from banapa, vegetation, perilla, or guava, and only plant hormones other than these are used. Compared to the callus, the efficiency of callus growth and triterpene production in the callus is significantly improved.
[0024] インドール酢酸と組み合わせて用いられる、インドール酢酸以外の植物ホルモンと しては、力イネチン、 1 ナフタレン酢酸、 6—べンジルアデニン等が挙げられ、特に力 イネチンが好適に採用できる。  [0024] Examples of plant hormones other than indoleacetic acid used in combination with indoleacetic acid include potato-inetin, 1-naphthaleneacetic acid, 6-benzylazidenine, and the like, and potato-inetin is particularly preferred.
[0025] また、カルスの培養は、 LS寒天培地等の固体培地において、無菌下、 20— 30°C、 暗所で行うことが好ましい。  [0025] The callus is preferably cultured in a solid medium such as LS agar medium under aseptic conditions at 20-30 ° C in a dark place.
[0026] 培養したカルス力 直接トリテルペン組成物を得ることもできるし、培養したカルスの 一部を別の新しい固体培地又は液体培地に移植して再度培養する、すなわち継代 培養を行ったカルスからトリテルペン組成物を得ることもできる。継代培養を繰り返し 行うことで、長期的に安定してトリテルペン組成物を得ることができる。  [0026] Cultivated callus power [0026] The triterpene composition can be obtained directly, or a part of the cultured callus is transplanted to another new solid medium or liquid medium and cultured again, that is, from the callus subjected to subculture. A triterpene composition can also be obtained. By repeating subculture, a triterpene composition can be stably obtained over a long period of time.
[0027] 継代培養は、先に培養したカルスの一部をそのまま用いて培養してもよ 、し、培養 したカルスの一部カゝらマイクロプラストを調製し、そのマイクロプラストを液体培地中で 懸濁培養させるなどしてもよい。継代培養を行う条件は、カルスを誘導する場合の、 上記した条件と同様であることが好ましい。また、継代培養における一代の培養期間 は 5— 30日間が好ましい。継代培養は、 目的とするトリテルペンのカルス中における 産生量が著しく減少しない限り、世代を更新させながら継続することができる。 [0027] In the subculture, a part of the previously cultured callus may be used as it is, or a microplast may be prepared from a part of the cultured callus, and the microplast may be placed in a liquid medium. May be used for suspension culture. The conditions for subculture are as follows: Preferably, the conditions are the same as those described above. In addition, the culture period for one passage in the subculture is preferably 5 to 30 days. The subculture can be continued while renewing the generation as long as the production amount of the target triterpene in the callus is not significantly reduced.
[0028] 上記のように培養されたカルス中に産生するトリテルペンの中でも、コロソリン酸及 びトルメンテイツク酸が薬理活性等の点で有用性が大きぐカルス中のコロソリン酸及 びトルメンテイツク酸の含有率が大きいことが好ましい。具体的には、マスリン酸と、マ スリン酸の重量に対して 4一 10倍量のコロソリン酸と、 2— 6倍量のトルメンテイツク酸と 、 1. 5— 4倍量の 2 α , 19 α—ジヒドロキシ一 3—ォキソ一ウノレス一 12—ェン一 28—ォイツ ク酸とを含むことが好まし 、。  [0028] Among the triterpenes produced in the callus cultured as described above, corosolic acid and tormentetic acid have great utility in terms of pharmacological activity and the like. Is preferably large. Specifically, maslinic acid, corosolic acid in an amount of 4 to 10 times the weight of maslinic acid, 2 to 6 times the amount of tolmentic acid, 1.5 to 4 times the amount of 2α, 19 α-dihydroxy-l-oxo-unoleth-l-l-en-28-oitic acid.
[0029] 特に、大きな血糖値低下作用を示すコロソリン酸を高純度で得ることを容易にする ために、カルス中におけるマスリン酸に対するコロソリン酸の比率が高いことが重要で ある。コロソリン酸とマスリン酸とは化学構造が極めて近いために、両者を分離するこ とが困難だ力 である。  [0029] In particular, it is important that the ratio of corosolic acid to maslinic acid in callus is high in order to easily obtain corosolic acid having a large blood sugar level lowering action with high purity. Since corosolic acid and maslinic acid have very similar chemical structures, it is difficult to separate them.
[0030] カルス中に含まれるトリテルペンの含有量を定量する方法としては、培養したカルス からメタノール等を用いて抽出した成分を液体クロマトグラフィーで分析し、得られた クロマトグラムの面積から定量する方法を好適に採用できる。  [0030] As a method of quantifying the content of triterpene contained in the callus, a method of analyzing components extracted from the cultured callus using methanol or the like by liquid chromatography and quantifying from the area of the obtained chromatogram is used. Can be suitably adopted.
[0031] 培養したカルスから、公知の方法を採用して抽出して得たエキスは、コロソリン酸、ト ノレメンテイツク酸、 2ひ, 19ひ一ジヒドロキシ一 3—才キソ一ウノレス一 12—ェン一 28—才イツ ク酸及びマスリン酸を多く含有するトリテルペン組成物である。このトリテルペン組成 物を健康食品等の原料として用いることもできるし、さらに精製して不要成分を除去し てもよい。  [0031] The extract obtained by extracting the cultured callus by using a known method is obtained by using corosolic acid, tonomenthetic acid, 2,19-dihydroxy-13-year-old quinone-unoleth-12-e. This is a triterpene composition containing a large amount of itic acid and maslinic acid. The triterpene composition can be used as a raw material for health foods or the like, or may be further purified to remove unnecessary components.
[0032] 培養したカルスからの抽出は、培養後の生のカルスを用いて行ってもよいし、乾燥 させて力も粉砕するなどしたカルスを用いて行ってもよ!、。  [0032] Extraction from the cultured callus may be performed using raw callus after the culture, or may be performed using a callus that has been dried and crushed with force!
[0033] 抽出溶媒としては、水又はメタノール、エタノール等のアルコール等の親水性溶媒 を用いることが好ましぐ加温した水 Ζアルコール混合溶媒を用いることがより好まし い。具体的には、乾燥したカルスの粉砕ィ匕物 (原料)にエタノール又はエタノール水 溶液(エタノール含量 50— 80重量%)を原料に対して 5— 20重量倍、好ましくは 8— 10重量倍カ卩えて、常温一 90°C好ましくは約 50— 85°Cの温度で 30分一 2時間加熱 還流し、この抽出を 2— 3回繰り返す方法を好適に採用できる。 As the extraction solvent, it is preferable to use a hydrophilic solvent such as water or an alcohol such as methanol or ethanol, and it is more preferable to use a heated water-alcohol mixed solvent. Specifically, a dry callus crushed material (raw material) is mixed with ethanol or an aqueous ethanol solution (ethanol content of 50 to 80% by weight) 5 to 20 times, preferably 8 to 10 times the weight of the raw material. Cook and heat at room temperature-90 ° C, preferably about 50-85 ° C for 30 minutes to 2 hours A method of refluxing and repeating this extraction 2-3 times can be suitably used.
[0034] 上記のようにして得られるトリテルペン組成物から、コロソリン酸、トルメンテイツク酸、 2 α , 19 αージヒドロキシー3 ォキソ一ウルス一 12—ェン 28 オイック酸又はマスリン 酸を単離、精製してそれぞれのトリテルペンを得ることもできる。これらトリテルペンの 単離と精製は、シリカゲルカラムクロマトグラフィーや、再結晶等の方法によって行うこ とがでさる。 [0034] From the triterpene composition obtained as described above, corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3-oxo-l-ul-12-en-28-ic acid or maslinic acid is isolated and purified. To obtain the respective triterpene. Isolation and purification of these triterpenes can be performed by methods such as silica gel column chromatography and recrystallization.
[0035] トリテルペン組成物の量が多い場合には、トリテルペン組成物を水に懸濁し、エー テルやへキサン等に分配して低極性成分を除 、てから、水層をダイアイオン ΗΡ-20 カラムクロマトグラフィー等を用いて水、メタノール及びアセトンにて順次溶出し、メタノ 一ル溶出画分をシリカゲルカラムクロマトグラフィー等で分離、精製を行うことが好まし い。  [0035] When the amount of the triterpene composition is large, the triterpene composition is suspended in water and distributed to ether or hexane to remove low-polar components, and then the aqueous layer is treated with diaion -20. It is preferable to sequentially elute with water, methanol and acetone using column chromatography or the like, and to separate and purify the methanol-eluted fraction by silica gel column chromatography or the like.
[0036] また、単離、精製して得られるトリテルペンの純度を高めるために、トリテルペン組成 物中のトリテルペンの水酸基をァセチル化したり、カルボキシル基をメチルエステル 化したりした状態でカラムクロマトグラフィーや再結晶等による精製を行った後、加水 分解して所望のトリテルペンを得る方法も好適に採用できる。  [0036] In addition, in order to increase the purity of the triterpene obtained by isolation and purification, column chromatography or recrystallization in which the hydroxyl group of the triterpene in the triterpene composition is acetylated or the carboxyl group is methyl esterified is performed. A method of obtaining the desired triterpene by carrying out purification by hydrolysis or the like, followed by hydrolysis, can also be suitably employed.
[0037] 上記のように単離、精製して得られるコロソリン酸、トルメンテイツク酸、 2 α , 19 α - ジヒドロキシー 3 ォキソ ウルス—12 ェンー 28 オイック酸又はマスリン酸は、それぞ れの一種のトリテルペンを少なくとも 90. 0重量%以上含むものであり、  [0037] Corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3-oxourus-12-en-28 euic acid or maslinic acid obtained by isolation and purification as described above are At least 90.0% by weight or more,
98. 0重量%以上含むことがより好ましぐ 99. 9重量%以上含むことがさらに好まし い。  More preferably, it contains 98.0% by weight or more, even more preferably 99.9% by weight or more.
[0038] 本発明のトリテルペン組成物は、上述した方法によって得られ、下記化学式(1)で 示されるコロソリン酸、下記化学式(2)で示されるトルメンテイツク酸、下記化学式(3) で示される 2 OL , 19 α—ジヒドロキシー 3 ォキソ一ウルス一 12 ェンー 28 オイック酸及 び下記化学式 (4)で示されるマスリン酸力 なる群より選ばれる少なくとも一種を含む トリテルペン組成物である。 [化 1] [0038] The triterpene composition of the present invention is obtained by the above-described method, and is represented by corosolic acid represented by the following chemical formula (1), tolmentic acid represented by the following chemical formula (2), and represented by the following chemical formula (3) 2 OL, 19 A triterpene composition containing α-dihydroxy-3oxo-l-ul-12-28-ic acid and at least one maslinic acid represented by the following chemical formula (4). [Chemical 1]
Figure imgf000008_0001
Figure imgf000008_0001
これらのトリテルペンを含むトリテルペン組成物は、それぞれ血糖値低下作用ゃ抗 腫瘍活性等の薬理活性を有することが知られており、健康食品や医薬などの原料と して用いることができる。また、これらのトリテルペンの中でも、薬理活性の強いコロソリ ン酸及びトルメンテイツク酸を含んで 、るトリテルペン組成物が特に有用性が高 、。 実施例 Triterpene compositions containing these triterpenes are known to have pharmacological activities such as blood glucose level lowering activity and antitumor activity, respectively, and can be used as raw materials for health foods and medicines. In addition, among these triterpenes, the highly pharmacologically active corosori Triterpene compositions containing carboxylic acid and tolmentic acid are particularly useful. Example
[0044] 以下に、実施例により本発明をさらに詳細に説明する力 本発明はこれらの実施例 に限定されるものではない。  Hereinafter, the present invention will be described in more detail with reference to Examples. The present invention is not limited to these Examples.
[0045] (カルスの誘導)  [0045] (Induction of callus)
バナノ から切り取った葉を次亜塩素酸ナトリウムに 15分間浸漬して滅菌処理した。 植物ホルモンとしてインドール酢酸 10 μ Μ及び力イネチン 10 μ Μを加え、 ρΗを 5. 8 とした LS寒天培地を三角フラスコ中に調製しておき、そこへ滅菌処理したバナパの 葉を置床し、 25°C、暗所下にて培養することにより、カルスが誘導された。  Leaves cut from the banana were immersed in sodium hypochlorite for 15 minutes and sterilized. LS agar medium with ρ 酢 酸 of 5.8 was prepared in an Erlenmeyer flask by adding 10 μΜ of indoleacetic acid and 10 μΜ of force inetine as plant hormones, and sterilized banana leaves were placed on the LS agar. The callus was induced by culturing in a dark place at ° C.
また、誘導されたカルスを 30日間培養した後、カルスの一部を別の LS寒天培地に 移植して培養したところ、移植したカルスが再び増殖するのが確認された。すなわち 、バナノくから誘導したカルスの継代培養を行うことができた。  After culturing the induced calli for 30 days, a portion of the callus was transplanted to another LS agar medium and cultured, and it was confirmed that the transplanted callus proliferated again. That is, the subculture of the callus derived from Banano was able to be performed.
[0046] (カルスの培養及びカルス中のトリテルペン含有量)  (Callus Culture and Triterpene Content in Callus)
誘導されたカルスを、インドール酢酸 10 M及び力イネチン 10 Mをカ卩えた LS寒 天培地にて 3週間培養して増殖させ、増殖したカルスをメタノールに冷浸して抽出し た成分について、高速液体クロマトグラフィー分析を行うことによって得たクロマトダラ ム(紫外吸光光度計、検出波長: 220nm)における、各トリテルペンに対応するピー クの面積から、培養したカルスのトリテルペン含有量を求めた。また、カルス誘導前の 原植物 (バナパ葉)中のトリテルペン含有量も同様の方法で求めた。結果を表 1に示 す。  The induced calli were cultured and grown on an LS agar medium supplemented with 10 M of indole acetic acid and 10 M of force inetine for 3 weeks, and the grown calli were extracted by cold immersion in methanol. The triterpene content of the cultured calli was determined from the area of the peak corresponding to each triterpene in the chromatogram (ultraviolet absorptiometer, detection wavelength: 220 nm) obtained by performing chromatographic analysis. In addition, the content of triterpene in the original plant (banapa leaf) before callus induction was determined by the same method. The results are shown in Table 1.
[0047] [表 1] [Table 1]
カルス 原植物 Callus original plant
トリテルペン "旦  Triterpene
3 里 重量比 3 里 重量比 3 ri weight ratio 3 ri weight ratio
[mg/g dry wt] [mg/g dry wt] [mg / g dry wt] [mg / g dry wt]
コロソリン酉 g 10.7 6.7 1 .1 5.5 トルメンテイツク酸 6.0 3.8 検出されず  Corosolin rooster g 10.7 6.7 1.1 .5 5.5 Tolmentic acid 6.0 3.8 Not detected
2 a , 1 9ひ一ジヒドロキシ一 3 _ 3.3 2.1 検出されず  2 a, 1 9 Hi-hydroxy 3 _ 3.3 2.1 Not detected
ォキソ一ウルス一 1 2—ェンー 2  Oxo-Urus 1 1 2—No 2
8 -オイック酸  8-Oic acid
ウルソ一ル酸 0.5 0.8 0.2 I .Q ォレアノール酸 0.4 0.3 0.1 0.5 マスリン酸 1 .6 1.0 0.2 1.0  Ursolic acid 0.5 0.8 0.2 I .Q Oleanolic acid 0.4 0.3 0.1 0.5 Maslinic acid 1.6 1.0 0.2 1.0
[0048] カルス中のコロソリン酸の含有量は、原植物に対して約 10倍に増加した。また、原 植物中には検出されなかったトルメンテイツク酸及び 2 a , 19 α—ジヒドロキシー 3—才 キソーウルス 12 ェンー 28 オイック酸は、カルスを誘導することによって初めて産生 することがわかった。 [0048] The corosolic acid content in the calli increased about 10-fold relative to the original plant. In addition, it was found that tormentetic acid and 2a, 19α-dihydroxy-3-year-old xourous 12-28-ic acid, which were not detected in the original plant, were produced only by inducing callus.
[0049] 一方、植物ホルモンとしてインドール酢酸のみ、又は力イネチンのみをそれぞれ加 えた LS寒天培地や、植物ホルモンを加えな!/、LS寒天培地でのカルスの培養を試み た力 これらの場合にはカルスの実質的な増殖は少な力つた。  [0049] On the other hand, LS agar medium to which only indole acetic acid or only force inetine was added as a plant hormone, or no plant hormone was added! / The force of trying to culture callus on LS agar medium Substantial callus growth was less vigorous.

Claims

請求の範囲 The scope of the claims
[1] バナパ、ビヮ、シソ又はグアノくから誘導されるカルスを、インドール酢酸及びこれ以 外の植物ホルモンとともに培養し、培養した前記カルスから、コロソリン酸、トルメンテ イツク酸、 2ひ, 19ひ一ジヒドロキシー3—才キソ一ウノレス一 12—ェン 28—才イツク酸及び マスリン酸カゝらなる群より選ばれる少なくとも一種を含むトリテルペン組成物を得るトリ テルペン組成物の製造方法。  [1] A callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones, and from the cultured callus, corosolic acid, tormentetic acid, 2, 19 A method for producing a triterpene composition, which comprises obtaining a triterpene composition containing at least one selected from the group consisting of monodihydroxy-3-isoquinone-1-12-28-acetic acid and maslinic acid.
[2] 前記培養が前記カルスの継代培養である、請求項 1に記載のトリテルペン組成物の 製造方法。 [2] The method for producing a triterpene composition according to claim 1, wherein the culture is a subculture of the callus.
[3] 前記カルスが、バナパ、ビヮ、シソ又はグアバの、葉、種子、茎、茎頂、根又は胚細 胞力 誘導されるカルスである、請求項 1又は 2に記載のトリテルペン組成物の製造 方法。  [3] The triterpene composition according to claim 1 or 2, wherein the callus is a calla of a leaf, a seed, a stem, a shoot apex, a root, or an embryonic cell force of banapa, vegetation, perilla, or guava. Manufacturing method.
[4] 培養した前記カルスが、マスリン酸と、マスリン酸の重量に対して 4一 10倍量のコロ ソリン酸と、 2— 6倍量のトルメンテイツク酸と、 1. 5— 4倍量の 2 α , 19 α—ジヒドロキシ 3 ォキソ ウルス—12 ェンー 28 オイック酸とを含む、請求項 1一 3の!、ずれか一 項に記載のトリテルペン組成物の製造方法。  [4] The cultured callus is composed of maslinic acid, corosolic acid in a quantity of 4 to 10 times the weight of maslinic acid, 2 to 6 times the amount of tolmentic acid, 1.5 to 4 times the weight of the maslinic acid. 14. The method for producing a triterpene composition according to claim 13, wherein the composition further comprises 2α, 19α-dihydroxy-3-oxourous-12-28-oic acid.
[5] 請求項 1一 4のいずれか一項に記載のトリテルペン組成物の製造方法によって得ら れ、コロソリン酸、トルメンテイツク酸、 2 α , 19 α—ジヒドロキシー3 ォキソ一ウルス一 12 ェンー 28 オイック酸及びマスリン酸力もなる群より選ばれる少なくとも一種を含むト リテルペン組成物。  [5] A method for producing a triterpene composition according to any one of claims 14 to 14, which is obtained by using corosolic acid, tolmentic acid, 2α, 19α-dihydroxy-3-oxo-l-urethane. 28 A triterpene composition comprising at least one selected from the group consisting of ic acid and maslinic acid.
[6] バナパ、ビヮ、シソ又はグアノくから誘導され、請求項 1一 4のいずれか一項に記載 のトリテルペン組成物の製造方法に用いるためのカルス。  [6] A callus derived from banapa, vegetation, perilla, or guano, for use in the method for producing a triterpene composition according to any one of claims 14 to 14.
[7] バナパ、ビヮ、シソ又はグアノくから誘導されるカルスを、インドール酢酸及びこれ以 外の植物ホルモンとともに培養し、培養した前記カルスから、コロソリン酸を含むトリテ ルペン組成物を得、当該トリテルペン組成物カゝらコロソリン酸を得るコロソリン酸の製 造方法。 [7] A callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones, and from the cultured callus, a triterpene composition containing corosolic acid is obtained. A method for producing corosolic acid to obtain a triterpene composition cura corosolic acid.
[8] 前記培養がカルスの継代培養である、請求項 7に記載のコロソリン酸の製造方法。  [8] The method for producing corosolic acid according to claim 7, wherein the culture is subculture of callus.
[9] 前記カルス力 バナパ、ビヮ、シソ又はグアバの、葉、種子、茎、茎頂、根又は胚細 胞力 誘導されるカルスである、請求項 7又は 8に記載のコロソリン酸の製造方法。 [9] The production of corosolic acid according to claim 7 or 8, wherein the callus force is a callus induced by leaf, seed, stem, shoot apex, root or embryo cell force of banapa, vegetation, perilla or guava. Method.
[10] バナパ、ビヮ、シソ又はグアノくから誘導されるカルスを、インドール酢酸及びこれ以 外の植物ホルモンとともに培養し、培養した前記カルスから、トルメンテイツク酸を含む トリテルペン組成物を得、当該トリテルペン組成物からトルメンテイツク酸を得るトルメ ンティック酸の製造方法。 [10] A callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones, and a triterpene composition containing tormentetic acid is obtained from the cultured callus, A method for producing tolmentic acid, which obtains tolmentic acid from the triterpene composition.
[11] 前記培養がカルスの継代培養である、請求項 10に記載のトルメンテイツク酸の製造 方法。  [11] The method for producing tormentetic acid according to claim 10, wherein the culture is a subculture of callus.
[12] 前記カルス力 バナパ、ビヮ、シソ又はグアバの、葉、種子、茎、茎頂、根又は胚細 胞力 誘導されるカルスである、請求項 10又は 11に記載のトルメンテイツク酸の製造 方法。  [12] The tormentetic acid according to claim 10 or 11, wherein the callus is a callus induced by leaf, seed, stem, shoot apex, root or embryo cell of vanapa, vegetation, perilla or guava. Manufacturing method.
[13] バナパ、ビヮ、シソ又はグアノくから誘導されるカルスを、インドール酢酸及びこれ以 外の植物ホルモンとともに培養し、培養した前記カルスから、 2 a , 19 α—ジヒドロキシ —3-ォキソ-ウルス- 12-ェン -28-オイック酸を含むトリテルペン組成物を得、当該ト リテルペン組成物から 2 α , 19 α—ジヒドロキシ— 3 ォキソ ウルス— 12—ェンー 28—才 イツク酸を得る 2 α , 19 α—ジヒドロキシ一 3 ォキソ一ウルス一 12—ェン 28 オイック酸 の製造方法。  [13] A callus derived from banapa, vegetation, perilla or guano is cultured with indoleacetic acid and other plant hormones, and 2a, 19α-dihydroxy-3-oxo- A triterpene composition containing urus-12-en-28-oic acid is obtained, and from the triterpene composition, 2α, 19α-dihydroxy-3-oxourus-12-en-28-year-old acid is obtained. 19 A method for producing α-dihydroxy-l-3oxo-l-ul-l2-ene 28-oic acid.
[14] 前記培養がカルスの ϋ代培養である、請求項 13に記載の 2 « , 19 0;—ジヒドロキシ 14. The method according to claim 13, wherein the culture is a primary culture of callus.
—3-ォキソ-ウルス— 12—ェン -28-オイック酸の製造方法。 —3-Oxo-Urus—Method for producing 12-en-28-oic acid.
[15] 前記カルス力 バナパ、ビヮ、シソ又はグアバの、葉、種子、茎、茎頂、根又は胚細 胞から誘導されるカルスである、請求項 13又は 14に記載の 2 α , 19 α—ジヒドロキシ15. The αα, 19 according to claim 13 or claim 14, wherein the callus power is a callus derived from leaves, seeds, stems, shoot tips, roots, or germ cells of banapa, vegetation, perilla, or guava. α-dihydroxy
—3-ォキソ-ウルス— 12—ェン -28-オイック酸の製造方法。 —3-Oxo-Urus—Method for producing 12-en-28-oic acid.
[16] バナパ、ビヮ、シソ又はグアノくから誘導されるカルスを、インドール酢酸及びこれ以 外の植物ホルモンとともに培養し、培養した前記カルスから、マスリン酸を含むトリテ ルペン組成物を得、当該トリテルペン組成物カゝらマスリン酸を得るマスリン酸の製造 方法。 [16] A callus derived from banapa, vegetation, perilla or guano is cultured with indole acetic acid and other plant hormones, and a triterpene composition containing maslinic acid is obtained from the cultured callus, A method for producing maslinic acid to obtain a triterpene composition masulinic acid.
[17] 前記培養がカルスの継代培養である、請求項 16に記載のマスリン酸の製造方法。  17. The method for producing maslinic acid according to claim 16, wherein the culture is a subculture of callus.
[18] 前記カルス力 バナパ、ビヮ、シソ又はグアバの、葉、種子、茎、茎頂、根又は胚細 胞力 誘導されるカルスである、請求項 16又は 17に記載のマスリン酸の製造方法。 [18] The production of maslinic acid according to claim 16 or 17, wherein the callus force is a callus induced by leaf, seed, stem, shoot apex, root, or embryo cell force of banapa, vegetation, perilla or guava. Method.
PCT/JP2004/019428 2003-12-26 2004-12-24 Process for producing triterpene composition WO2005063227A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005516669A JPWO2005063227A1 (en) 2003-12-26 2004-12-24 Method for producing triterpene composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003433867 2003-12-26
JP2003-433867 2003-12-26

Publications (1)

Publication Number Publication Date
WO2005063227A1 true WO2005063227A1 (en) 2005-07-14

Family

ID=34736535

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/019428 WO2005063227A1 (en) 2003-12-26 2004-12-24 Process for producing triterpene composition

Country Status (3)

Country Link
JP (1) JPWO2005063227A1 (en)
KR (1) KR20060123377A (en)
WO (1) WO2005063227A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009500013A (en) * 2005-06-30 2009-01-08 サムヤン ジェネックス コーポレイション Method for producing corosolic acid by plant cell suspension culture
JP6906830B1 (en) * 2021-03-17 2021-07-21 株式会社東洋新薬 Oral compositions, muscle-building compositions and anti-obesity compositions

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BEGUM S. ET AL: "Triterpenoids from the leaves of Psidium guajava", PHYTOCHEMISTRY, vol. 61, no. 4, 2002, pages 399 - 403, XP004385769 *
CHEN J.H. ET AL: "High-performance liquid chromatographic analysis of bioactive triterpenes in Perilla frutescens", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 32, no. 6, 21 August 2003 (2003-08-21), pages 1175 - 1179, XP002985090 *
MURAKAMI C. ET AL: "Screening of plant constituents for effect on glucose transport activity on Ehrlich ascites tumor cells", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 41, no. 12, 1993, pages 2129 - 2131, XP000887220 *
OSMAN A.M. ET AL: "Chemical examination of local plants. Part VII", EGYPTIAN JOURNAL OF CHEMISTRY, vol. 18, no. 2, 1975, pages 347 - 352, XP002985091 *
TANIGUCHI S. ET AL: "Production of bioactive triterpenes by Eriobotrya japonica calli", PHYTOCHEMISTRY, vol. 59, no. 3, 2002, pages 315 - 323, XP004335024 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009500013A (en) * 2005-06-30 2009-01-08 サムヤン ジェネックス コーポレイション Method for producing corosolic acid by plant cell suspension culture
JP4769868B2 (en) * 2005-06-30 2011-09-07 サムヤン ジェネックス コーポレイション Method for producing corosolic acid by plant cell suspension culture
US8101411B2 (en) 2005-06-30 2012-01-24 Samyang Genex Corporation Method for production of corosolic acid in suspension culture of plant cells
JP6906830B1 (en) * 2021-03-17 2021-07-21 株式会社東洋新薬 Oral compositions, muscle-building compositions and anti-obesity compositions
JP2022143483A (en) * 2021-03-17 2022-10-03 株式会社東洋新薬 Oral composition, muscle-building composition, and anti-obesity composition

Also Published As

Publication number Publication date
JPWO2005063227A1 (en) 2007-07-19
KR20060123377A (en) 2006-12-01

Similar Documents

Publication Publication Date Title
JP4769868B2 (en) Method for producing corosolic acid by plant cell suspension culture
Agarwal et al. Micropropagation and validation of genetic homogeneity of Alhagi maurorum using SCoT, ISSR and RAPD markers
Oncina et al. Bioproduction of diosgenin in callus cultures of Trigonella foenum-graecum L.
Luo et al. Micropropagation of Dendrobium densiflorum Lindl. ex Wall. through protocorm-like bodies: effects of plant growth regulators and lanthanoids
JP5951491B2 (en) Method for producing triptolide
WO2013106975A1 (en) Preparation method, agricultural composition and applications of natural brassinolide analogs
KR20140122533A (en) Mass propagation method for adventitious root of Astragali Radix containing the increased amount of Astragaloside IV
Kuzovkina et al. Flavonoid production in transformed Scutellaria baicalensis roots and ways of its regulation
Khandy et al. Obtaining and study of callus and suspension plant cell cultures of Tribulus terrestris L., a producer of steroidal glycosides
CN115851572A (en) Method for increasing glabridin content in suspension culture cell of liquorice
Park et al. Medicinal orchids: production of bioactive compounds and biomass
Cheng et al. Production of flavonoids and terpene lactones from optimized Ginkgo biloba tissue culture
Jeong et al. Effect of plant growth regulators on growth and biosynthesis of phenolic compounds in genetically transformed hairy roots of Panax ginseng CA Meyer
Ramawat et al. Guggulsterone: a potent natural hypolipidemic agent from Commiphora wightii–problems, perseverance, and prospects
RU2360964C1 (en) CULTURE OF ROOT STRAIN Hed th (Hedysarum theinum Krasnob) - PRODUCER OF ISOFLAVONS
JPH02231023A (en) Raising seedling of genus pinelliae or genus angelic plant
US20050255569A1 (en) Method for producing triterpene composition
WO2005063227A1 (en) Process for producing triterpene composition
WO2007107803A2 (en) Process and modified media for preparing callus- and cell suspension cultures of hypericum perforatum l.
Mangas et al. Centella asiatica (L) Urban: An updated approach
JPH03262488A (en) Production of podophyllotoxin compound
RU2296155C1 (en) Strain of cultured cells of plants serratula coronata l
Singh et al. Influence of growth regulators on the explants of Commiphora mukul (Hook. ex Stocks) Engl. under in vitro conditions
AU700033B2 (en) Pilocarpin production process
KR101810412B1 (en) Method for Culturing Adventitious Roots of Pseudolarix Amabilis in Media Containing Extracts of Brown Rices through Ultrasonic Treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005516669

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020067012541

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 1020067012541

Country of ref document: KR

122 Ep: pct application non-entry in european phase